embed embed2
  • Prodex-B Drug A Possible Cure For COVID-19? 'Baseless,' The FDA Says

    The agency issued a warning earlier this week
    by Lei Dimarucut-Sison .
Prodex-B Drug A Possible Cure For COVID-19? 'Baseless,' The FDA Says
PHOTO BY @nndanko/iStock
  • Claims that a drug combination called "Prodex-B" can cure those who are suffering from COVID-19 are "baseless," the Food and Drug Administration (FDA) said on Monday.

    Prodex-B is said to be a mix of three different drugs: Procaine, Dexamethasone, and Vitamin B — thus, Prodex-B.

    "The drug combination of Procaine and Dexamethasone with Vitamin B called 'Prodex-B' is circulating in various media platforms and claims that it has promising effects against viral infections and diseases. 

    "However upon verification, the drug product 'Prodex-B' is unregistered in this Office," FDA Advisory No. 2020-452 said.

    More from Smart Parenting

    According to the advisory, procaine is an anesthetic — a drug used to manage pain, or literally, to induce temporary loss of sensation.

    Dexamethasone, a corticosteroid, helps ease swelling and itching and is used to treat asthma or arhtritis. The FDA, however, warns that it can bring about side effects like a "weaker immune system leading to vulnerability to infections."

    ADVERTISEMENT - CONTINUE READING BELOW

    CONTINUE READING BELOW
    Recommended Videos

    Because Prodex-B is not registered with the FDA, the agency added that it cannot guarantee the quality, safety, and efficacy of the drug.

    The FDA advised those who have taken the drug Prodex-B to be vigilant about experiencing side effects, and to seek medical attention immediately if they do.  

    As of yet, there is still no cure for COVID-19, although clinical trials for a vaccine is underway.

    ADVERTISEMENT - CONTINUE READING BELOW
    More from Smart Parenting

     

Get the latest stories on COVID-19.
All you need to know from your trusted Summit Media network. Sign up here for regular updates delivered to your mailbox.
The email address you entered is invalid.
Thank you for signing up. We'll send updates directly to your inbox!
View More Stories About
Trending in Summit Network
View more articles